---
figid: PMC7989705__CTM2-11-e356-g005
figlink: pmc/articles/PMC7989705/figure/ctm2356-fig-0002/
number: F2
caption: Solute carriers (SLCs) associated with PDAC cell proliferation, angiogenesis,
  invasion, and metastasis. (A) Glutamine is transported into tumor cells by SLC1A5
  and can be used as an efflux substrate by the SLC7A5/SLC3A2 complex to mediate the
  uptake of essential amino acids (EAAs), finally activating the mTOR pathway to promote
  cell proliferation and angiogenesis., ,  Overexpression of c‐Myc induces the expression
  of SLC7A5, which further activates mTOR signaling. (B) The SLC7A11/SLC3A2 complex
  (system Xc−) regulates the uptake of cystine against the efflux of L‐glutamate,
  which further activates the PI3K/Akt signaling pathway to promote cell proliferation.
  The proliferation of tumor cells is also inhibited by miR‐139‐5p expression via
  the PI3K/AKT signaling pathway. (C) Overexpression of SLC39A4 upregulates the transcription
  of IL‐6 through CREB, which activates STAT3 to increase cell proliferation and tumor
  progression. SLC39A4 induces the transcription of miR‐373, which inhibits the transcription
  of TP53INP1, LATS2, and CD44 to promote tumor growth. (D) Inhibition of SLC6A14
  decreases tumor cell proliferation by suppressing the mTOR pathway
pmcid: PMC7989705
papertitle: Emerging roles of the solute carrier family in pancreatic cancer.
reftext: Zijian Wu, et al. Clin Transl Med. 2021 Mar;11(3):e356.
pmc_ranked_result_index: '10942'
pathway_score: 0.9410812
filename: CTM2-11-e356-g005.jpg
figtitle: Solute carriers (SLCs) associated with PDAC cell proliferation, angiogenesis,
  invasion, and metastasis
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7989705__CTM2-11-e356-g005.html
  '@type': Dataset
  description: Solute carriers (SLCs) associated with PDAC cell proliferation, angiogenesis,
    invasion, and metastasis. (A) Glutamine is transported into tumor cells by SLC1A5
    and can be used as an efflux substrate by the SLC7A5/SLC3A2 complex to mediate
    the uptake of essential amino acids (EAAs), finally activating the mTOR pathway
    to promote cell proliferation and angiogenesis., ,  Overexpression of c‐Myc induces
    the expression of SLC7A5, which further activates mTOR signaling. (B) The SLC7A11/SLC3A2
    complex (system Xc−) regulates the uptake of cystine against the efflux of L‐glutamate,
    which further activates the PI3K/Akt signaling pathway to promote cell proliferation.
    The proliferation of tumor cells is also inhibited by miR‐139‐5p expression via
    the PI3K/AKT signaling pathway. (C) Overexpression of SLC39A4 upregulates the
    transcription of IL‐6 through CREB, which activates STAT3 to increase cell proliferation
    and tumor progression. SLC39A4 induces the transcription of miR‐373, which inhibits
    the transcription of TP53INP1, LATS2, and CD44 to promote tumor growth. (D) Inhibition
    of SLC6A14 decreases tumor cell proliferation by suppressing the mTOR pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC6A14
  - SLC3A2
  - SLC39A4
  - SLC7A11
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - STAT3
  - IL6
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - MYC
  - TP53INP1
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - LATS2
  - CD44
  - Na
  - Glu
  - Zn
  - NAA
  - phosphate
  - amino acid
genes:
- word: SLC6A14
  symbol: SLC6A14
  source: hgnc_symbol
  hgnc_symbol: SLC6A14
  entrez: '11254'
- word: SL7ĄS/SLC3A2
  symbol: SLC3A2
  source: hgnc_symbol
  hgnc_symbol: SLC3A2
  entrez: '6520'
- word: SLC39A4
  symbol: SLC39A4
  source: hgnc_symbol
  hgnc_symbol: SLC39A4
  entrez: '55630'
- word: SLC7A11/SLC3A2
  symbol: SLC7A11
  source: hgnc_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: SLC7A11/SLC3A2
  symbol: SLC3A2
  source: hgnc_symbol
  hgnc_symbol: SLC3A2
  entrez: '6520'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: (TP53INP1
  symbol: TP53INP1
  source: hgnc_symbol
  hgnc_symbol: TP53INP1
  entrez: '94241'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: LATS2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: -SLC7AS,SLC3A2
  symbol: SLC3A2
  source: hgnc_symbol
  hgnc_symbol: SLC3A2
  entrez: '6520'
- word: SLC6A14
  symbol: SLC6A14
  source: hgnc_symbol
  hgnc_symbol: SLC6A14
  entrez: '11254'
- word: SLC7A11,SLC3A2
  symbol: SLC7A11
  source: hgnc_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: SLC7A11,SLC3A2
  symbol: SLC3A2
  source: hgnc_symbol
  hgnc_symbol: SLC3A2
  entrez: '6520'
- word: SLC39A4
  symbol: SLC39A4
  source: hgnc_symbol
  hgnc_symbol: SLC39A4
  entrez: '55630'
chemicals:
- word: Na
  source: MESH
  identifier: D012964
- word: Glu
  source: MESH
  identifier: C094686
- word: Zn
  source: MESH
  identifier: D015032
- word: NAA
  source: MESH
  identifier: D009536
- word: phosphate
  source: MESH
  identifier: D010710
- word: amino acid
  source: MESH
  identifier: D000596
diseases: []
figid_alias: PMC7989705__F2
redirect_from: /figures/PMC7989705__F2
figtype: Figure
---
